Clo­vis spikes ovar­i­an can­cer com­bo af­ter 'un­der­whelm­ing' ef­fi­ca­cy; Servi­er wins pri­or­i­ty re­view for Tib­so­vo ex­pan­sion

Clo­vis On­col­o­gy up­dat­ed in­vestors with its first quar­ter re­sults on Wednes­day morn­ing, and among its rev­e­la­tions proved some trou­bling news for a Bris­tol My­ers Squibb …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER